{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:14:34Z","timestamp":1792696474955,"version":"4.5.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:00Z","timestamp":1467158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Within the last several years, the National Institutes of Health has supported three randomized clinical trials to determine whether lower than usually recommended goals for treatment of hypertension would have greater benefit for prevention of cardiovascular disease and stroke. These were the ACCCORD, SPRINT, and Secondary Prevention of Small Subcortical Strokes (SPS3) Trials. Together they enrolled 17,114 participants. Results for all three have been reported. The trials differ from each other in their inclusion criteria, target blood pressures for the lower goal (intensive treatment), but are similar in many respects. The results with regard to their primary outcome were different: not significant for ACCORD and SPS3, but definitely significant for SPRINT. Subgroup analysis revealed differences and similarities. When viewed together and with recent large observational studies, they support a conclusion that a systolic pressure in the range of 125\u2013135 mm Hg range is likely to be optimal on treatment for most hypertensive patients.<\/jats:p>","DOI":"10.1093\/ajh\/hpw065","type":"journal-article","created":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T02:44:00Z","timestamp":1467254640000},"page":"1020-1023","source":"Crossref","is-referenced-by-count":13,"title":["A Tale of 3 Trials: ACCORD, SPRINT, and SPS3. What Happened?"],"prefix":"10.1093","volume":"29","author":[{"given":"Lawrence R.","family":"Krakoff","sequence":"first","affiliation":[{"name":"Department of Medicine\/Cardiology, Icahn School of Medicine at Mount Sinai 1 , New York, New York , USA ."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,6,29]]},"reference":[{"key":"2024012405581221600_CIT0001","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"2024012405581221600_CIT0002","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/HJH.0000000000000881","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels\u2014updated overview and meta-analyses of randomized trials","volume":"34","author":"Thomopoulos","year":"2016","journal-title":"J Hypertens"},{"key":"2024012405581221600_CIT0003","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"The ACCORD Study Group","year":"2010","journal-title":"N Engl J Med"},{"key":"2024012405581221600_CIT0004","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"The SPRINT Research Group","year":"2015","journal-title":"N Engl J Med"},{"key":"2024012405581221600_CIT0005","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"key":"2024012405581221600_CIT0006","article-title":"Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged &gt;\/=75 years: a randomized clinical trial","author":"Williamson","year":"2016","journal-title":"JAMA"},{"key":"2024012405581221600_CIT0007","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/HYPERTENSIONAHA.115.06236","article-title":"Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with diabetes mellitus: action to control cardiovascular risk in diabetes blood pressure trial","volume":"66","author":"Soliman","year":"2015","journal-title":"Hypertension"},{"key":"2024012405581221600_CIT0008","article-title":"Effect of intensive blood pressure lowering on incident atrial fibrillation and P-wave indices in the ACCORD blood pressure trial","author":"Chen","year":"2015","journal-title":"Am J Hypertens"},{"key":"2024012405581221600_CIT0009","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/HYPERTENSIONAHA.115.06480","article-title":"Achieved blood pressure and outcomes in the secondary prevention of small subcortical strokes trial","volume":"67","author":"Odden","year":"2016","journal-title":"Hypertension"},{"key":"2024012405581221600_CIT0010","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/gerona\/glv228","article-title":"Characterizing frailty status in the systolic blood pressure intervention trial","volume":"71","author":"Pajewski","year":"2016","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2024012405581221600_CIT0011","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1001\/jamainternmed.2014.4520","article-title":"Risks and benefits of antihypertensive medications in older adults\u2013reply","volume":"174","author":"Tinetti","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2024012405581221600_CIT0012","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/archinternmed.2012.2555","article-title":"Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty","volume":"172","author":"Odden","year":"2012","journal-title":"Arch Intern Med"},{"key":"2024012405581221600_CIT0013","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(14)61212-5","article-title":"Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data","volume":"384","author":"Blood Pressure Lowering Treatment Trialists Collaboration","year":"2014","journal-title":"Lancet"},{"key":"2024012405581221600_CIT0014","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/HJH.0b013e32836123aa","article-title":"Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: cohort study of 34009 primary care patients","volume":"31","author":"Sundstrom","year":"2013","journal-title":"J Hypertens"},{"key":"2024012405581221600_CIT0015","doi-asserted-by":"crossref","first-page":"e5567","DOI":"10.1136\/bmj.e5567","article-title":"Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study","volume":"345","author":"Vamos","year":"2012","journal-title":"Br Med J"},{"key":"2024012405581221600_CIT0016","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1097\/HJH.0b013e3283577bdf","article-title":"Blood pressure and risk of cardiovascular diseases in type 2 diabetes: further findings from the Swedish National Diabetes Register (NDR-BP II)","volume":"30","author":"Cederholm","year":"2012","journal-title":"J Hypertens"},{"key":"2024012405581221600_CIT0017","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"key":"2024012405581221600_CIT0018","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.amjmed.2010.02.014","article-title":"Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy","volume":"123","author":"Denardo","year":"2010","journal-title":"Am J Med"},{"key":"2024012405581221600_CIT0019","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/HYPERTENSIONAHA.111.179143","article-title":"Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease: J-curve revisited","volume":"59","author":"Dorresteijn","year":"2012","journal-title":"Hypertension"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/article\/29\/9\/1020\/2622270","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article\/29\/9\/1020\/2622270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T05:58:25Z","timestamp":1706075905000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/29\/9\/1020\/2622270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,29]]},"references-count":19,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,6,29]]},"published-print":{"date-parts":[[2016,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpw065","relation":{},"ISSN":["1941-7225","0895-7061"],"issn-type":[{"value":"1941-7225","type":"electronic"},{"value":"0895-7061","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,9]]},"published":{"date-parts":[[2016,6,29]]}}}